1-4 of 4
Michael Bitzer
Close
Sort by
Journal Articles

Antibody-induced procoagulant platelets in severe COVID-19 infection

Karina Althaus, Irene Marini, Jan Zlamal, Lisann Pelzl, Anurag Singh, Helene Häberle, Martin Mehrländer, Stefanie Hammer, Harald Schulze, Michael Bitzer, Nisar Malek, Dominik Rath, Hans Bösmüller, Bernard Nieswandt, Meinrad Gawaz, Tamam Bakchoul, Peter Rosenberger
Journal: Blood
Blood (2021) 137 (8): 1061–1071.
https://doi.org/10.1182/blood.2020008762
Published: 2021
Includes: Supplemental data
Journal Articles

Direct and Natural Killer Cell-Mediated Anti-Tumor Effects of Low-Dose Bortezomib in Hepatocellular Carcinoma.

Matthias Krusch, MD, Sorin Armeanu, PhD, Katrin M. Baltz, Ulrich M. Lauer, MD, Alexander Steinle, PhD, Lothar Kanz, MD, Michael Bitzer, MD, Helmut R. Salih, MD
Journal: Blood
Blood (2007) 110 (11): 4181.
https://doi.org/10.1182/blood.V110.11.4181.4181
Published: 2007
Journal Articles

Severe Impairment of Dendritic Cell Allostimulatory Activity by Sendai Virus Vectors Is Overcome by Matrix Protein Gene Deletion.

Sorin Armeanu, MD, Michael Bitzer, Irina Smirnov, Sascha Bossow, Silke Appel, PhD, Guy Ungerechts, Christian Bernloehr, Lothar Kanz, MD, Wolfgang J. Neubert, Ulrich M. Lauert, Peter Brossart, MD
Journal: Blood
Blood (2005) 106 (11): 5535.
https://doi.org/10.1182/blood.V106.11.5535.5535
Published: 2005
Journal Articles

NK Cell Recognition of Hepatocellular Carcinoma by Specific Induction of NKG2D Ligands Following Treatment with the Histone Deacetylase Inhibitor Sodium Valproate.

Helmut R. Salih, MD, Sorin Armeanu, PhD, Ulrich M. Lauer, MD, Sascha Venturelli, Anita Pathil, Irina Smirnow, Annika Wagner, Lothar Kanz, MD, Alexander L. Steinle, PhD, Michael Bitzer, MD
Journal: Blood
Blood (2004) 104 (11): 1340.
https://doi.org/10.1182/blood.V104.11.1340.1340
Published: 2004